培米替尼在北京买一盒多少钱
Pemigatinib is used to treat patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements. Pemigatinib is a selective fibroblast growth factor receptor (FGFR) inhibitor that inhibits FGFR1, FGFR2, and FGFR3. Pemigatinib is the first and only targeted therapy for cholangiocarcinoma in the United States, the European Union, and Japan. Pemigatinib can prevent the growth and spread of tumor cells by blocking FGFR2 in tumor cells. Is pemigatinib available in China? How much does it cost to buy a box in Beijing?
It is understood that pemigatinib is currently on the market in Hong Kong, China, but has not yet been launched in mainland China. Therefore, patients cannot purchase the drug in Beijing pharmacies, and the drug price of pemigatinib in Beijing cannot be provided. If patients want to know the specific price information of pemigatinib in Hong Kong, China, as well as the price and purchase channels of pemigatinib in other overseas countries or regions, they can consult domestic professional overseas medical service companies (such as Medical Travel).
Pemetinib related clinical trials
The results of the clinical trial code-named FIGHT-202 showed that among 107 patients with FGFR2 fusion/rearrangement, all patients responded to treatment. The overall response rate of pemigatinib monotherapy was 36%, including 2.8% complete response and 33% partial response; the disease control rate was 82%. Median duration of response was 9.1 months; 63% of patients achieved response for 6 months or longer, and 18% maintained response for 12 months or longer.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)